Csamm 2014 Abstract Book
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Comparison of the Treatment Practice And
RESEARCH ARTICLE Comparison of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Malaysia: A cross sectional study Kun Yun Lee1*, Wan Azman Wan Ahmad2, Ee Vien Low3, Siow Yen Liau4,5, a1111111111 Lawrence Anchah6, Syuhada Hamzah7, Houng-Bang Liew5,8, Rosli B. Mohd Ali9, a1111111111 Omar Ismail10, Tiong Kiam Ong11, Mas Ayu Said1, Maznah Dahlui1 a1111111111 a1111111111 1 Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, 2 Division of Cardiology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala a1111111111 Lumpur, Malaysia, 3 Pharmaceutical Services Division, Ministry of Health, Selangor, Malaysia, 4 Department of Pharmacy, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 5 Clinical Research Centre, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 6 Department of Pharmacy, Sarawak General Hospital Heart Centre, Sarawak, Malaysia, 7 Administrative Office, Penang General Hospital, Penang, Malaysia, 8 Division of Cardiology, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 9 Department of Cardiology, National Heart Institute, Kuala Lumpur, Malaysia, 10 Division of Cardiology, Penang General Hospital, Penang, Malaysia, 11 Department of OPEN ACCESS Cardiology, Sarawak General Hospital Heart Centre, Sarawak, Malaysia Citation: Lee KY, Wan Ahmad WA, Low EV, Liau SY, Anchah L, Hamzah S, et al. (2017) Comparison * [email protected] of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Abstract Malaysia: A cross sectional study. PLoS ONE 12 (9): e0184410. https://doi.org/10.1371/journal. pone.0184410 Editor: Yoshihiro Fukumoto, Kurume University Introduction School of Medicine, JAPAN The increasing disease burden of coronary artery disease (CAD) calls for sustainable car- Received: May 15, 2017 diac service. -
300512 CPG Management of Stroke Copy
I CLINICAL PRACTICE GUIDELINES DEVELOPMENT GROUP AUTHORS (in alphabetical order) PROF DR HAMIDON BASRI Consultant Neurologist Chairperson University Putra Malaysia, Selangor A/PROF DR CHIN SZE PIAW Consultant Cardiologist International Medical University, KL DR LOOI IRENE Consultant Neurologist Hospital Seberang Jaya, Penang DR MAK CHOON SOON Consultant Neurologist Gleneagles Hospital, KL A/PROF DR MOHAMED SOBRI MUDA Consultant Neuroradiologist University Kebangsaan Malaysia Medical Centre, KL DATO’ DR MD. HANIP RAFIA Consultant Neurologist Hospital Kuala Lumpur, KL PROF DR TAN KAY SIN Consultant Neurologist University Malaya Medical Centre, KL DR ZARIAH ABDUL AZIZ Consultant Neurologist Hospital Sultanah Nur Zahirah, Terengganu EXTERNAL REVIEWERS (in alphabetical order) DR HJ BAHANORDIN BIN JAAFAR Physician of Rehabilitation Medicine Hospital Serdang, Selangor PROF DR GOH KHEAN JIN Consultant Neurologist University Malaya Medical Centre, KL DATO’ DR LOH THIAM GHEE Consultant Neurologist Sime Darby Medical Centre, Selangor DATO’ DR MOHD RANI JUSOH Consultant Neurologist Ampang Puteri Hospital, KL DATO’ DR MUHAMMAD RADZI BIN ABU HASSAN Consultant Physician Hospital Sultanah Bahiyah, Kedah ASSOC PROF DR NOOR AZAH ABD AZIZ Family Medicine Specialist University Kebangsaan Malaysia Medical Center, KL PROF DATO’ DR RAYMOND AZMAN ALI Consultant Neurologist University Kebangsaan Malaysia Medical Centre, KL PROF DR TAN CHONG TIN Consultant Neurologist University Malaya Medical Centre, KL II RATIONALE AND PROCESS OF GUIDELINE DEVELOPMENT Rationale Stroke is a leading cause of death and disability in Malaysia. Thus, guidelines on the management are imperative to ensure best available therapy is instituted. The clinical practice guidelines (CPG) on ischaemic stroke was developed to provide clear and concise approach to all clinicians on the current concepts in the management of ischaemic stroke patients. -
MJPCH 2010 (Dec); Vol. 1; Supplementary 2
MJPCH 2010 (Dec); Vol. 16; Supplementary 2 MJPCH 2010 (Dec); Vol. 1; Supplementary 2 In conjunction with 32ND MALAYSIAN PAEDIATRIC ASSOCIATION ANNUAL CONGRESS 14-17TH OCTOBER 2010 HILTON HOTEL, KULA LUMPUR ABSTRACTS ORGANISED BY MALAYSIAN PAEDIATRIC ASSOCIATION MJPCH 2010 (Dec); Vol. 16; Supplementary 2 Content YOUNG INVESTIGATOR AWARD PAPERS YIA 1 ASSESSMENT OF MORTALITY PREDICTION TOOLS IN PAEDIATRIC INTENSIVE CARE UNIT UMMC AND ESTABLISHING A NOVEL PAEDIATRIC INTENSIVE CARE REGISTRY (PEDICARE2008) 1 Anis Siham Zainal Abidinl1, LCS Lum2, N Ismail3, M Sabri4 YIA 2 PREVALENCE OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) INTERMEDIATE IN THE NEWBORNS AND THE ACCURACY OF SEMI- QUANTITATIVE FLUORESCENT SPOT TEST (FST) AS SCREENING TOOL 2 Azizan Aziz1, Thong MK2, Lim CT2 YIA 3 JUVENILE IDIOPATHIC ARTHRITIS IN MALAYSIA: THE SELAYANG EXPERIENCE 3 Cham Weng Tarng, Tang Swee Ping YIA 4 HEALTH-RELATED QUALITY OF LIFE IN SABAH CHILDREN WITH TRANSFUSION 4 DEPENDENT THALASSAEMIA Choong Yee Wan, Lee Chee Chan YIA 5 HYPOTHYROXINAEMIA IN PRETERM INFANTS IN SPECIAL CARE NURSERY (SCN), UNIVERSITY MALAYA MEDICAL CENTRE (UMMC) 5 Hannah Wardiah Rosland, Chin-Theam Lim, Fatimah Harun YIA 6 CORONARY ARTERY ABNORMALITY IN COMPLETE KAWASAKI DISEASE CHILDREN 6 TREATED WITH IMMUNOGLOBULIN Amelia Alias1, Chan TL2, Mohd Amin Itam1, Mat Bah MN1 ORAL PRESENTSTIONS ORAL PRESENTATIONS 1 OP1.1 A DESCRIPTIVE STUDY OF APNOEA OF PREMATURITY IN INFANTS LESS THAN 34 WEEKS OF GESTATION AND A COMPARATIVE STUDY OF ORAL CAFFEINE VERSUS ORAL AMINOPHYLLINE IN THE TREATMENT OF APNOEA OF PREMATURITY 7 Lim Boon Soo, Lim Chin Theam OP1.2 HUMAN RHINOVIRUSES AMONG CHILDREN HOSPITALISED WITH ACUTE LOWER RESPIRATORY TRACT INFECTIONS 8 Mohamad Reza Etemadi1, Farid Azizi Jalilian1, Norrashidah Abdul Wahab3, Zamberi Sekawi1, Putri Yubbu2, Zurina Zainudin2, Shamarina Shohaimi4, Norlijah Othman2 MJPCH 2010 (Dec); Vol. -
Journal of the ASEAN Federation of Endocrine Societies
Journal of the JournalASEAN of the Federation of ASEANEndocrine Federation Societies of EndocrineVolume No. 34 Special EditionSocieties | ISSN 2308-118x (Online) Vol. 32 No. 2 November 2017 | ISSN 0857-1074 | eISSN 2308-118x 2019 1| 0 Pre-Congress: 18 July 2019 Congress: 19 - 21 July 2019 Hilton & Le Méridien Kuala Lumpur, Malaysia The Journal of the ASEAN Federation of Endocrine Societies (JAFES) is an open-access, peer-reviewed, English language, medical and health science journal that is published two times a year by the ASEAN Federation of Endocrine Societies (AFES). Its editorial policies are aligned with the policies of the International Committtee of Medical Journal Editors (www.icmje.org). SIMPLIFYING THE COMPLEXITY OF ENDOCRINOLOGY JAFES welcomes manuscripts on all aspects of endocrinology and metabolism in the form of original articles, review articles, case reports, feature articles (clinical practice guidelines, clinical case seminars, clinical practice guidelines, book reviews, et cetera), editorials, letters to the Editor, brief communications and special announcements. Authors may include members and non-members of the AFES. Authors are required to accomplish, sign and submit scanned copies of the JAFES Author Form consisting of:Messages (1) Authorship Certification, that the manuscript has been read and approved by all authors, and that the requirements for authorship have been met by each Organisingauthor; (2) the Author Declaration & Scientific, that the article Committee represents original material that is not being considered for publication or has not been published or accepted for publication elsewhere; (3) the Statement of Copyright Transfer [accepted manuscripts become the permanent property of the JAFES and are licensed Listwith an ofAttribution Faculty-Share Alike-Non-Commercial Creative Commons License. -
ASEAN Federation of Endocrine Societies
Journal of the JournalASEAN of the Federation of ASEANEndocrine Federation Societies of EndocrineVolume No. 36 Special EditionSocieties | ISSN 2308-118x (Online) Event ID: CPDE25340 20 Points Vol. 32 No. 2 November 2017 | ISSN 0857-1074 | eISSN 2308-118x VIRTUAL 30th July to 1st August 2021 www.memsmac.org The Journal of the ASEAN Federation of Endocrine Societies (JAFES) is an open-access, peer-reviewed, English language, medical and health science journal that is published two times a year by the ASEAN Federation of Endocrine Societies (AFES). Its editorial policies are aligned with the policies of the International Committtee of Medical Journal Editors (www.icmje.org). JAFES welcomes manuscripts on all aspects of endocrinology and metabolism in the form of original articles, reviewU Narticles,RAVELLING case reports, feature articles T HE I NTRICACIES IN E NDOCRINOLOGY (clinical practice guidelines, clinical case seminars, clinical practice guidelines, book reviews, et cetera), editorials, letters to the Editor, brief communications and special announcements. Authors may include members and non-members of the AFES. Authors are required to accomplish, sign and submit scanned copies of the JAFES Author Form consisting of:Messages (1) Authorship Certification, that the manuscript has been read and approved by all authors, and that the requirements for authorship have been met by each Organisingauthor; (2) the Author Declaration & Scientific, that the article Committee represents original material that is not being considered for publication or has not been published or accepted for publication elsewhere; (3) the Statement of Copyright Transfer [accepted manuscripts become the permanent property of the JAFES and are licensed Listwith an ofAttribution Faculty-Share Alike-Non-Commercial Creative Commons License. -
CRM-Bulletin-Issue-07
By Clinical Research Malaysia ISSUE of Clinical Research and Therapy 07 DRIVERS OF CHANGE IN ENDOCRINOLOGY Research Personality: Putrajaya Hospital – Dr. Zanariah Hussein Malaysia’s Endocrine Centre Consultant Endocrinologist and Physician Hospital Putrajaya Working with CRM to move Malaysia forward When passion drives research: Pragmatic approach to cluster Greentown Health Clinic randomized trials ABOUT CLINICAL RESEARCH MALAYSIA Clinical Research Malaysia (CRM) is a non-prot company wholly owned by the Government of Malaysia’s Ministry of Health. CRM was established in June 2012 to position Malaysia as a preferred global destination for industry-sponsored research (ISR) and to function as an enabler and facilitator to the industry and medical fraternity. By working with other stakeholders, CRM strives to improve the local ecosystem to support growth in ISR, facilitate the needs and requirements of industry players, grow the pool of capable investigators, support staff and trial sites, and improve their capabilities and capacities to conduct ISR. With the Ministry of Health’s backing and clear knowledge of the local research environment, CRM is able to provide sponsors (primarily from the pharmaceutical, biotech and medical device industries) and contract research organizations (CRO) with an extensive range of services that includes feasibility studies, investigator selection, placement and development of study coordinators, management of trial budget, review of clinical trial agreements and updates on local laws, guidelines and regulations. CRM also undertakes marketing and promotional activities to build industry awareness about the opportunities for ISR in Malaysia, and create public and patient awareness of clinical trials. 1 CONTENTS From the CEO’s desk 3 Malaysia’s ISR Statistics (Jan– Oct ’15) 4 Medical Research and Ethics Committee (MREC) Updates 6 Research Personality Dr. -
Malaysian Journal of Pharmacy Vol.4 Issue 1, July 2018 ______
Vol. 2 Issue 2. August 2016 Vol.4 Issue 1. July 2018 MALAYSIANMALAYSIAN JOURNALJOURNALof ofPHARMACY PHARMACY Supplement: Proceedingsofthe9th National Pharmacy R&D In this issue:Conference 2016 Serial Drama: Seven Steps to Avoid Falling Foul of Falsified Medicines Directive (FMD) Management of Mild Valproic Acid Toxicity with Hemodialysis – A Case Report Stability of Extemporaneously Compounded Chloral Hydrate Oral Solution Supplement Proceedings of the 10th National Pharmacy R&D Conference 2018 APublicationoftheMalaysianPharmaceuticalSociety EDITORIAL BOARD A Publication of the Malaysian Pharmaceutical Society Malaysian Journal of Pharmacy Vol.4 Issue 1, July 2018 ___________________________________________________________________ The Official Journal of the Malaysian Pharmaceutical Society Editor-in-Chief: Assoc. Prof. Dr. Asrul Akmal Shafie Managing Editor: Mr. Ho Rhu Yann International Advisory Board: Assoc. Prof. Dr. Chua Siew Siang Prof. Dr. Mohd Baidi Bahari Associate Editors: Mr. Lam Kai Kun Prof. Dr. Mohamed Azmi Ahmad Hassali Assoc. Prof. Dr. Mohamad Haniki Nik Mohamed Ms. Syireen Alwi Prof. P T Thomas Dr. Wong Tin Wui Assoc. Prof. Dr. Vikneswaran a/l Murugaiyah Prof. Dr. Yuen Kah Hay Publisher: Malaysian Pharmaceutical Society 16-2 Jalan OP 1/5, 1-Puchong Business Park Off Jalan Puchong 47160 Puchong Malaysia Tel: 6-03-80791861 Fax: 6-03-80700388 Homepage: www.mps.org.my Email: [email protected] The Malaysian Journal of Pharmacy is a publication of the Malaysian Pharmaceutical Society. Enquiries are to be directed to the publisher at the above address. The Publisher reserves copy- right and renewal on all published materials, and such material may not be reproduced in any form without the written permission of the Publisher. -
ASEAN Federation of Endocrine Societies
Journal of the JournalASEAN of the Federation of ASEANEndocrine Federation Societies of EndocrineVolume No. 36 Special EditionSocieties | ISSN 2308-118x (Online) Event ID: CPDE25340 20 Points Vol. 32 No. 2 November 2017 | ISSN 0857-1074 | eISSN 2308-118x VIRTUAL 30th July to 1st August 2021 www.memsmac.org The Journal of the ASEAN Federation of Endocrine Societies (JAFES) is an open-access, peer-reviewed, English language, medical and health science journal that is published two times a year by the ASEAN Federation of Endocrine Societies (AFES). Its editorial policies are aligned with the policies of the International Committtee of Medical Journal Editors (www.icmje.org). JAFES welcomes manuscripts on all aspects of endocrinology and metabolism in the form of original articles, reviewU Narticles,RAVELLING case reports, feature articles T HE I NTRICACIES IN E NDOCRINOLOGY (clinical practice guidelines, clinical case seminars, clinical practice guidelines, book reviews, et cetera), editorials, letters to the Editor, brief communications and special announcements. Authors may include members and non-members of the AFES. Authors are required to accomplish, sign and submit scanned copies of the JAFES Author Form consisting of:Messages (1) Authorship Certification, that the manuscript has been read and approved by all authors, and that the requirements for authorship have been met by each Organisingauthor; (2) the Author Declaration & Scientific, that the article Committee represents original material that is not being considered for publication or has not been published or accepted for publication elsewhere; (3) the Statement of Copyright Transfer [accepted manuscripts become the permanent property of the JAFES and are licensed Listwith an ofAttribution Faculty-Share Alike-Non-Commercial Creative Commons License. -
National Heart Association of Malaysia
National Heart Association of Malaysia YIA 1 YIA 2 SUBCLINICAL MYOCARDIAL DIASTOLIC DYSFUNCTION IN IMPACT OF PRE-OPERATIVE ASSESSMENT OF MYOCARDIAL PATIENTS WITH HIGH C-REACTIVE PROTEIN ASYMPTOMATIC VIABILITY USING CMR VS ECHOCARDIOGRAPHY ALONE ON 1 SYSTEMIC LUPUS ERYTHEMATOSUS IN ASIAN POPULATION YEAR SURVIVAL AND EF IN PATIENTS WITH POOR LV FUNCTION Tan SK1, Teh CL2, Chua SK1, Yew KL1, Nor Hanim1, Chang BC1, Alan FYY1, Annuar R3Ong TK1, UNDERGOING CABG Sim KH1 Nor Hanim MA1, R Annuar2, BC Chang1, SK Chua1, Fong AYY1, KL Yew1, NZ Kiew1, YL Cham1, 1Department of Cardiology, Sarawak General Hospital 2Rheumatology Unit, Sarawak General Hospital Ong TK1 , KH Sim1 3Universiti Sarawak Malaysia (UNIMAS) 1 Cardiology Department, Sarawak General Hospital, 2Universiti Malaysia Sarawak.(UNIMAS) Sarawak, Malaysia. BACKGROUND Systemic lupus erythematosus (SLE) causes significant vascular, myocardial and pericardial inflammation leading to significant cardiovascular morbidity and mortality. Serum C-Reactive BACKGROUND: Patients with poor left ventricular (LV) function have poorer outcome after coronary Protein (CRP) level parallels with inflammatory state in rheumatoid arthritis. However, CRP response in artery bypass grafting (CABG). The adjunctive use of late gadolinium enhanced cardiac MRI (CMR) to SLE inflammatory state is different. assess myocardial viability may be a better strategy than using echocardiography alone. OBJECTIVE To determine subclinical myocardial diastolic dysfunction in asymptomatic SLE Asian OBJECTIVE: To compare 1 year survival and change in LV ejection fraction (LVEF) in CABG patients patients and its relation to CRP. with and without a viability study METHOLOGY This is a prospective cohort study. 68 Asian patients with confirmed diagnosis of SLE in inactive stage, no known coronary artery disease or lung disease and not in heart failure undergone METHODS AND MATERIALS:: This is a retrospective study of all CABG patients in Sarawak General standard transthoracic echocardiography and tissue Doppler imaging. -
Comparison of the Treatment Practice and Hospitalization Cost Of
RESEARCH ARTICLE Comparison of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Malaysia: A cross sectional study Kun Yun Lee1*, Wan Azman Wan Ahmad2, Ee Vien Low3, Siow Yen Liau4,5, a1111111111 Lawrence Anchah6, Syuhada Hamzah7, Houng-Bang Liew5,8, Rosli B. Mohd Ali9, a1111111111 Omar Ismail10, Tiong Kiam Ong11, Mas Ayu Said1, Maznah Dahlui1 a1111111111 1 Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, a1111111111 Malaysia, 2 Division of Cardiology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala a1111111111 Lumpur, Malaysia, 3 Pharmaceutical Services Division, Ministry of Health, Selangor, Malaysia, 4 Department of Pharmacy, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 5 Clinical Research Centre, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 6 Department of Pharmacy, Sarawak General Hospital Heart Centre, Sarawak, Malaysia, 7 Administrative Office, Penang General Hospital, Penang, Malaysia, 8 Division of Cardiology, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 9 Department of Cardiology, National Heart Institute, Kuala Lumpur, Malaysia, 10 Division of Cardiology, Penang General Hospital, Penang, Malaysia, 11 Department of OPEN ACCESS Cardiology, Sarawak General Hospital Heart Centre, Sarawak, Malaysia Citation: Lee KY, Wan Ahmad WA, Low EV, Liau SY, Anchah L, Hamzah S, et al. (2017) Comparison * [email protected] of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Abstract Malaysia: A cross sectional study. PLoS ONE 12 (9): e0184410. https://doi.org/10.1371/journal. pone.0184410 Editor: Yoshihiro Fukumoto, Kurume University Introduction School of Medicine, JAPAN The increasing disease burden of coronary artery disease (CAD) calls for sustainable car- Received: May 15, 2017 diac service. -
Ninth Report of the Malaysian Dialysis and Transplant Registry 2001 Ready by July of 2002
NINTH REPORT OF THE MALAYSIAN DIALYSIS AND TRANSPLANT REGISTRY 2001 edited by T. O. LIM Y. N. LIM NATIONAL RENAL REGISTRY (NRR) c/o Department of Nephrology Hospital Kuala Lumpur Jalan Pahang 50586 Kuala Lumpur Malaysia Tel No: 603 2698 4882 Fax No: 603 2691 6514 Email: [email protected] Web site: http://www.crc.gov.my/nrr ACKNOWLEDGMENTS The National Renal Registry Committee would like to thank all who have contributed work hard to get this Ninth Report of the Malaysian Dialysis and Transplant Registry 2001 ready by July of 2002. We would like to especially thank the following: All centre coordinators, staff, nephrologists and physicians in-charge of dialysis centres and renal units from the various government, non-governmental and private centres without whose dedication, hard work and timely data collection and submission this registry report would not be possible. Ms. Lee Day Guat for her tireless and meticulous effort as data manager Ms Mardhiah bt Arifin, Nur Azliana bt Ramli and Norasiken bt Lajis @ Aziz for their help in data entry The Ministry of Health, Malaysia for assistance seen and unseen. And of course not forgetting our major sponsors: Baxter Medi-Chem Fresenius Medical Care Janssen-Cilag MX Services / Gambro and other sponsors: Novartis Diethelm Malaysia / Vifor International NATIONAL RENAL REGISTRY COMMITTEE I PARTICIPATING CENTRES FEDERAL TERRITORY Government Kuala Lumpur Hospital Labuan Hospital Pusat Hemodialisis KEMENTAH Putrajaya Hospital Universiti Kebangsaan Malaysia Hospital University Malaya Medical Centre NGO Charis-NKF Dialysis Centre, Cheras MAA-Medicare Charity Dialysis Centre, Cheras MAA-Medicare Charity Dialysis Centre, Kuala Lumpur NKF Dialysis Centre, Kuala Lumpur Pusat Hemodialisis Yayasan Felda Rotary Club Damansara-NKF Dialysis Centre, Kepong The Nayang-NKF Dialysis Centre, Setapak Private Lifeline Dialysis Clinic, Kuala Lumpur Pantai Medical Centre, Kuala Lumpur Pusat Pakar Tawakal Renal Dialysis Centre, Gleneagles Intan Medical Centre Renal Healthcare, Kuala Lumpur Renal-Link Sentosa S.P. -
Malaysian Journal of Pharmacy (Vol 2 Issue 2)
PP12684/8/2008 Vol. 2 Issue 2. August 2016 MALAYSIAN JOURNAL of PHARMACY In this issue: Supplement • Proceedings of the 9th National Pharmacy R&D Conference 2016 A Publication of the Malaysian Pharmaceutical Society PP12684/8/2008 Vol. 2 Issue 2. August 2016 MALAYSIAN JOURNAL of PHARMACY In this issue: Supplement • Proceedings of the 9th National Pharmacy R&D Conference 2016 A Publication of the Malaysian Pharmaceutical Society PP12684/8/2008 Vol. 2 Issue 2. August 2016 MALAYSIAN JOURNAL of PHARMACY In this issue: Supplement • Proceedings of the 9th National Pharmacy R&D Conference 2016 A Publication of the Malaysian Pharmaceutical Society EDITORIAL BOARD Malaysian Journal of Pharmacy Vol. 2 Issue 2. August 2016 The Official Journal of the Malaysian Pharmaceutical Society Editor-in-Chief: Assoc Prof Dr Asrul Akmal Shafie Managing Editor: Mr Ho Rhu Yann International Advisory Board: Assoc Prof Dr Chua Siew Siang Prof Dr Mohd Baidi Bahari Associate Editors: Mr Lam Kai Kun Prof Dr Mohamed Azmi Ahmad Hassali Assoc Prof Dr Mohamad Haniki Nik Mohamed Ms Syireen Alwi Prof P T Thomas Dr Wong Tin Wui Assoc Prof Dr Vikneswaran a/l Murugaiyah Prof Dr Yuen Kah Hay Publisher: Malaysian Pharmaceutical Society Malaysian Journal of Pharmacy 16-2 Jalan OP 1/5, 1-Puchong Business Park (the official journal of the Malaysian Off Jalan Puchong Pharmaceutical Society) 47160 Puchong c/o School of Pharmaceutical Sciences Malaysia Universiti Sains Malaysia Tel: 6-03-80791861 11800 Penang Fax: 6-03-80700388 MALAYSIA Homepage: www.mps.org.my Email: [email protected] Email: [email protected] The Malaysian Journal of Pharmacy is a publication of the Malaysian Pharmaceutical Society.